These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12234325)

  • 1. Mycophenolate mofetil treatment for primary glomerular diseases.
    Levin ML
    Kidney Int; 2002 Oct; 62(4):1475. PubMed ID: 12234325
    [No Abstract]   [Full Text] [Related]  

  • 2. Mycophenolate mofetil (MMF) therapeutic approach in patients with chronic glomerulonephritis (GN).
    Bullo B; Zdrojewski Z; Rutkowski B
    Kidney Int; 2003 Sep; 64(3):1139. PubMed ID: 12911571
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy of mycophenolate mofetil for steroid and cyclosporine resistant membranoproliferative glomerulonephritis type I.
    Ito S; Tsutsumi A; Inaba A; Machida H; Harada T; Yokota S
    Pediatr Nephrol; 2009 Aug; 24(8):1593-4. PubMed ID: 19224249
    [No Abstract]   [Full Text] [Related]  

  • 4. Cryoglobulinemic membranoproliferative glomerulonephritis: beyond conventional therapy.
    Colucci G; Manno C; Grandaliano G; Schena FP
    Clin Nephrol; 2011 Apr; 75(4):374-9. PubMed ID: 21426893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycophenolate mofetil: implications for the treatment of glomerular disease.
    Badid C; Desmouliere A; Laville M
    Nephrol Dial Transplant; 2001 Sep; 16(9):1752-6. PubMed ID: 11522852
    [No Abstract]   [Full Text] [Related]  

  • 6. [Benefits of mycophenolate mofetil in non-transplant kidney diseases].
    Parotte MC; Bovy C; Krzesinski JM
    Rev Med Suisse; 2007 Aug; 3(122):1899-901, 1903-5. PubMed ID: 17896664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycophenolate mofetil use in hepatitis B associated-membranous and membranoproliferative glomerulonephritis induces viral replication.
    Sayarlioglu H; Erkoc R; Dogan E; Sayarlioglu M; Topal C
    Ann Pharmacother; 2005 Mar; 39(3):573. PubMed ID: 15671086
    [No Abstract]   [Full Text] [Related]  

  • 8. Mycophenolate mofetil for Crohn's disease.
    Atherton JC
    Gut; 2000 May; 46(5):740-1. PubMed ID: 10836856
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of atopic dermatitis with mycophenolate mofetil.
    Hansen ER; Buus S; Deleuran M; Andersen KE
    Br J Dermatol; 2000 Dec; 143(6):1324-6. PubMed ID: 11122047
    [No Abstract]   [Full Text] [Related]  

  • 10. Is mycophenolate mofetil a new alternative in the treatment of inflammatory bowel disease?
    Present DH
    Gut; 1999 May; 44(5):592-3. PubMed ID: 10205187
    [No Abstract]   [Full Text] [Related]  

  • 11. Pancreatitis and duodenitis from sarcoidosis: successful therapy with mycophenolate mofetil.
    O'Connor AS; Navab F; Germain MJ; Freeman JK; Mulhern JG; O'Shea MH; Lipkowitz GS; Madden RL; Braden GL
    Dig Dis Sci; 2003 Nov; 48(11):2191-5. PubMed ID: 14705827
    [No Abstract]   [Full Text] [Related]  

  • 12. Mycophenolate mofetil.
    Surjushe A; Saple DG
    Indian J Dermatol Venereol Leprol; 2008; 74(2):180-4. PubMed ID: 18388396
    [No Abstract]   [Full Text] [Related]  

  • 13. Mycophenolate mofetil treatment of a patient with hyperglobulinemic purpura.
    Waldman MA; Callen JP
    J Am Acad Dermatol; 2004 Oct; 51(4):667-9. PubMed ID: 15455483
    [No Abstract]   [Full Text] [Related]  

  • 14. Successful treatment of severe refractory atopic dermatitis with mycophenolate mofetil.
    Grundmann-Kollmann M; Korting HC; Behrens S; Leiter U; Krähn G; Kaufmann R; Peter RU; Kerscher M
    Br J Dermatol; 1999 Jul; 141(1):175-6. PubMed ID: 10417549
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of five haemodynamically stable dogs with immune-mediated thrombocytopenia using mycophenolate mofetil as single agent.
    Yau VK; Bianco D
    J Small Anim Pract; 2014 Jun; 55(6):330-3. PubMed ID: 24602067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of systemic lupus erythematosus with mycophenolate mofetil.
    Adu D; Cross J; Jayne DR
    Lupus; 2001; 10(3):203-8. PubMed ID: 11315353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycophenolate mofetil is effective for maintenance therapy of hypocomplementaemic urticarial vasculitis.
    Worm M; Sterry W; Kolde G
    Br J Dermatol; 2000 Dec; 143(6):1324. PubMed ID: 11122046
    [No Abstract]   [Full Text] [Related]  

  • 18. Successful long-term treatment of severe atopic dermatitis with mycophenolate mofetil.
    Benez A; Fierlbeck G
    Br J Dermatol; 2001 Mar; 144(3):638-9. PubMed ID: 11260038
    [No Abstract]   [Full Text] [Related]  

  • 19. [Mycophenolate mofetil--a new therapeutic agent for chronic autoimmune diseases].
    Harboe E; Gøransson L; Wildhagen K; Omdal R
    Tidsskr Nor Laegeforen; 2005 Jun; 125(12):1650-2. PubMed ID: 15976831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acute tubulointerstitial nephritis associated with uveitis (TINU). Treatment of the ocular inflammation with mycophenolate mofetil].
    Sánchez Román J; Castillo Palma MJ; Ocaña Medina C; Rueda Rueda T
    Med Clin (Barc); 1998 Nov; 111(16):638. PubMed ID: 9881342
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.